Top Markets
#1 Ontology Ontology +44.87%
#2 Bedrock Bedrock +24.56%
#3 Naoris Protocol Naoris Protocol +20.60%
#4 TARS AI TARS AI +20.15%
#5 bitcastle Token bitcastle Token +20.01%
#6 DeFiChain DeFiChain +19.51%
#7 ETHGas ETHGas +19.47%
#8 pippin pippin +19.32%
#9 Chrema Coin Chrema Coin +15.54%
#10 DUSK Network DUSK Network +15.52%
Coin of the day
Ontology Ontology
Setări
Limbă
ROMâNă
Monedă
USD
Temă
Eli Lilly Eli Lilly

Eli Lilly

LLY
Rang în acțiuni #15
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals... Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, Trajenta, and Trulicity for type 2 diabetes. The company provides Alimta for non-small cell lung cancer (NSCLC) and malignant pleural mesothelioma; Cyramza for metastatic gastric cancer, gastro-esophageal junction adenocarcinoma, metastatic NSCLC, metastatic colorectal cancer, and hepatocellular carcinoma; Erbitux for colorectal cancers, and various head and neck cancers; Retevmo for metastatic NSCLC, medullary thyroid cancer, and thyroid cancer; Tyvyt for relapsed or refractory classic Hodgkin's lymph and non-squamous NSCLC; and Verzenio for HR+, HER2- metastatic breast cancer, node positive, and early breast cancer. It offers Olumiant for rheumatoid arthritis; and Taltz for plaque psoriasis, psoriatic arthritis, ankylosing spondylitis, and non-radiographic axial spondylarthritis. The company offers Cymbalta for depressive disorder, diabetic peripheral neuropathic pain, generalized anxiety disorder, fibromyalgia, and chronic musculoskeletal pain; Emgality for migraine prevention and episodic cluster headache; and Zyprexa for schizophrenia, bipolar I disorder, and bipolar maintenance. Its Bamlanivimab and etesevimab, and Bebtelovimab for COVID-19; Cialis for erectile dysfunction and benign prostatic hyperplasia; and Forteo for osteoporosis. The company has collaborations with Incyte Corporation; Boehringer Ingelheim Pharmaceuticals, Inc.; AbCellera Biologics Inc.; Junshi Biosciences; Regor Therapeutics Group; Lycia Therapeutics, Inc.; Kumquat Biosciences Inc.; Entos Pharmaceuticals Inc.; and Foghorn Therapeutics Inc. Eli Lilly and Company was founded in 1876 and is headquartered in Indianapolis, Indiana.
Preț acțiune
$910.55
Capitalizare de piață
$860.30B
Schimbare (1 zi)
0.44%
Schimbare (1 an)
5.28%
Țară
US
Tranzacționează Eli Lilly (LLY)

Categorie

Healthcare
Raport P/B pentru Eli Lilly (LLY)
Raport P/B la data de March 2026 TTM: 33.34
Conform celor mai recente rapoarte financiare și prețului acțiunilor Eli Lilly, raportul P/B actual (TTM) este 33.34. La sfârșitul anului 2024, compania avea un P/B de 48.99.
Istoricul raportului P/B pentru Eli Lilly din 2000 până în 2026
Raport P/B la sfârșitul fiecărui an
An Raport P/B Schimbă
2026 (TTM) 33.34 -100.00%
2025 0.00 -100.00%
2024 48.99 0.66%
2023 48.67 49.11%
2022 32.64 11.26%
2021 29.34 2.47%
2020 28.63 -40.70%
2019 48.27 298.96%
2018 12.10 57.86%
2017 7.67 32.61%
2016 5.78 -9.56%
2015 6.39 28.23%
2014 4.98 54.29%
2013 3.23 -15.65%
2012 3.83 12.02%
2011 3.42 9.59%
2010 3.12 -24.25%
2009 4.12 -37.07%
2008 6.54 51.79%
2007 4.31 -16.39%
2006 5.16 -9.59%
2005 5.70 1.26%
2004 5.63 -27.31%
2003 7.75 -6.41%
2002 8.28 -30.49%
2001 11.91 -28.36%
2000 16.63 0.00%
Raport P/B pentru companii similare sau competitoare
Companie Raport P/B Diferență raport P/B Țara
AstraZeneca PLC AstraZeneca PLC
AstraZeneca PLC
AZN.US
 6.0657 -81.81%
GB
Johnson & Johnson Johnson & Johnson
Johnson & Johnson
JNJ.US
 7.1931 -78.42%
US
AbbVie Inc. AbbVie Inc.
AbbVie Inc.
ABBV.US
 -119.6075 -458.78%
US
Novartis AG Novartis AG
Novartis AG
NVS.US
 6.3334 -81.00%
CH
Merck & Co., Inc. Merck & Co., Inc.
Merck & Co., Inc.
MRK.US
 5.4725 -83.58%
US